Science News
from research organizations

Some diabetes drugs may increase risk of bladder cancer

Date:
July 3, 2012
Source:
Canadian Medical Association Journal
Summary:
An increased risk of bladder cancer is linked to the use of pioglitazone, a medication commonly used to treat Type 2 diabetes, according to a new study.
Share:
         
Total shares:  
FULL STORY

An increased risk of bladder cancer is linked to the use of pioglitazone, a medication commonly used to treat type 2 diabetes, according to a new study published in CMAJ (Canadian Medical Association Journal).

People with type 2 diabetes are at risk of several types of cancer, including a 40% increased risk of bladder cancer, compared to people without diabetes. Previous studies have shown a higher incidence of bladder cancer in people taking pioglitazone, a type of thiazolidinedione.

To determine whether there is a link between pioglitazone use and bladder cancer, researchers conducted a systematic review and meta-analysis of randomized controlled trials and observational studies involving over 2.6 million patients.

"We observed an increased risk of bladder cancer associated with the use of thiazolidinediones," writes Dr. Jeffrey Johnson, School of Public Health, University of Alberta, with coauthors. "In particular, use of pioglitazone was associated with an increased risk of bladder cancer based on a pooled estimate from three cohort studies involving more than 1.7 million individuals."

The researchers also looked at a possible association with rosiglitazone, another type of thiazolidinedione, but did not see an effect.

"Although the absolute risk of bladder cancer associated with pioglitazone was small, other evidence-based treatments for type 2 diabetes may be equally effective and do not carry a risk of cancer," conclude the authors. "This study quantifies the association between pioglitazone use and bladder cancer and may help inform decisions around safer use of pioglitazone in individuals with type 2 diabetes."


Story Source:

The above story is based on materials provided by Canadian Medical Association Journal. Note: Materials may be edited for content and length.


Journal Reference:

  1. Isabelle N. Colmers et al. Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis. Canadian Medical Association Journal, 2012 DOI: 10.1503/cmaj.112102

Cite This Page:

Canadian Medical Association Journal. "Some diabetes drugs may increase risk of bladder cancer." ScienceDaily. ScienceDaily, 3 July 2012. <www.sciencedaily.com/releases/2012/07/120703161703.htm>.
Canadian Medical Association Journal. (2012, July 3). Some diabetes drugs may increase risk of bladder cancer. ScienceDaily. Retrieved April 26, 2015 from www.sciencedaily.com/releases/2012/07/120703161703.htm
Canadian Medical Association Journal. "Some diabetes drugs may increase risk of bladder cancer." ScienceDaily. www.sciencedaily.com/releases/2012/07/120703161703.htm (accessed April 26, 2015).

Share This Page:


Health & Medicine News
April 26, 2015

Latest Headlines
updated 12:56 pm ET